|
Index of reports
> Cases resulting in disability (7)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in disability.
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-10-30
Patient: 53 year old female, weighing 56.8 kg (124.9 pounds)
Adverse reactions / side effects: Deep Vein Thrombosis
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Premarin
Dosage: oral
Administration route: Oral
Indication: Menopause
Start date: 1997-02-01
End date: 1997-12-01
Prempro
Other drugs received by patient: Monopril
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-10-30
Patient: 53 year old female, weighing 56.8 kg (124.9 pounds)
Adverse reactions / side effects: Deep Vein Thrombosis
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Premarin
Dosage: oral
Administration route: Oral
Indication: Menopause
Start date: 1997-02-01
End date: 1997-12-01
Prempro
Other drugs received by patient: Monopril
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-17
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: disablity
Suspect drug(s):
Premarin
Prempro
Indication: Hormone Replacement Therapy
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-12
Patient: female
Adverse reactions / side effects: Ischaemic Cardiomyopathy, Thrombosis, Breast Cancer Metastatic, Respiratory Failure, Coronary Artery Occlusion, Pulmonary Oedema, Myocardial Infarction
Adverse event resulted in: disablity
Suspect drug(s):
Medroxyprogesterone Acetate
Premarin
Prempro
Indication: Hormone Replacement Therapy
Provera
Adverse event in 57 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-03-23
Patient: 57 year old female, weighing 87.1 kg (191.6 pounds)
Adverse reactions / side effects: Peripheral Coldness, Atelectasis, Wound Infection Staphylococcal, Groin Pain, Thrombophlebitis Superficial, Oedema Peripheral, Wound Infection Bacterial, Arteriosclerosis, Aneurysm Repair, Cardiac Failure Congestive, Peripheral Artery Aneurysm, Thrombectomy, Erythema Nodosum, Arterial Bypass Operation, Limb Discomfort, Arthralgia, Intermittent Claudication, Iliac Artery Occlusion, Peripheral Arterial Occlusive Disease, Gait Disturbance, Escherichia Infection, Hypertension, Deep Vein Thrombosis
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Estraderm
Indication: Hormone Replacement Therapy
Start date: 1990-07-13
End date: 1996-01-01
Premarin
Dosage: 0.625 mg, qd
Administration route: Oral
Indication: Hormone Replacement Therapy
Prempro
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-06-03
Other drugs received by patient: Synthroid; Naprosyn; Aspirin; Aspirin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-03-08
Patient: female
Adverse reactions / side effects: Nipple Pain, Breast Cancer in Situ, Electrocardiogram Ambulatory Abnormal, Mammogram Abnormal, Laboratory Test Abnormal, Palpitations, Uterine Leiomyoma, Chest Pain, Injury, Ventricular Extrasystoles, Intervertebral Disc Protrusion, Nausea, Supraventricular Extrasystoles, Arrhythmia, Emotional Distress, Anxiety, Rhinitis Allergic, Syncope, Presyncope, Scar
Adverse event resulted in: disablity
Suspect drug(s):
Climara ^schering^
Dosage: 0.1 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1997-07-01
Estrace
Dosage: 1 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1997-06-27
Premarin
Dosage: 0.062 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-03-08
Vivelle
Dosage: 0.05 mg/day, unk
Indication: Hormone Replacement Therapy
Start date: 1996-06-20
Adverse event in 51 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-02-28
Patient: 51 year old female, weighing 88.4 kg (194.6 pounds)
Adverse reactions / side effects: Vocal Cord Thickening, Electrocardiogram ST-T Change, Breast Cancer in Situ, Hot Flush, Breast Cyst, Palpitations, Fibroadenoma of Breast, Breast Microcalcification, Injury, Ventricular Extrasystoles, Dyspnoea, Mastitis, Malignant Breast Lump Removal, Mammary Duct Ectasia, Anxiety, Emotional Distress, Dysphonia, Insomnia, Breast Tenderness, Breast Abscess, Abscess, Scar
Adverse event resulted in: disablity
Suspect drug(s):
Alora
Climara ^schering^
Dosage: 0.1 mg/day, unk
Indication: Hormone Replacement Therapy
Premarin
Dosage: 0.625 mg/day, 3 q 4 weeks
Indication: Hormone Replacement Therapy
End date: 1983-01-01
Vivelle
Indication: Hormone Replacement Therapy
Vivelle-DOT
Dosage: 0.025 mg/day, q3 days
Indication: Hormone Replacement Therapy
Start date: 1999-06-29
End date: 2001-05-03
Other drugs received by patient: Bellergal-S
|
